Investor Relations

Latest Financial Results

Q1 2024

Quarter Ended Mar 31, 2024

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Company Overview

MyMD, Inc. (NASDAQ: MYMD) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. MyMD is traded on the Nasdaq under the ticker symbol MYMD

Investor Contact Information


MyMD Pharmaceuticals, Inc.
855 N. Wolfe Street
Suite 601
Baltimore, MD 21205

Investor Relations

Robert Schatz
T: 646-421-9523

Transfer Agent

Securities Transfer Corporation
2901 N Dallas Parkway
Suite 380
Plano, Texas 75093

  • This field is for validation purposes and should be left unchanged.